(Q38923237)

English

Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Sue Harnan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Praveen Thokala

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ruth Wong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Clara Mukuria

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Clare Green

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Simon Pledge

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

John Tidy

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

1 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

97-109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-016-0440-X

21 January 2018

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS40273-016-0440-X

21 January 2018

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS40273-016-0440-X

21 January 2018

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40273-016-0440-X

21 January 2018

Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey

1 reference

https://api.crossref.org/works/10.1007%2FS40273-016-0440-X

21 January 2018

Changing patterns in place of cancer death in England: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS40273-016-0440-X

21 January 2018

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

1 reference

https://pubmed.ncbi.nlm.nih.gov/27506954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK

1 reference

https://pubmed.ncbi.nlm.nih.gov/27506954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NICE guidance on bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27506954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide

1 reference

https://pubmed.ncbi.nlm.nih.gov/27506954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40273-016-0440-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27506954%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38923237&oldid=2202299808"